NASDAQ:LOAN - Manhattan Bridge Capital Stock Price, Forecast & News

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital announced a quarterly dividend on Wednesday, October 23rd. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.12 per share on Wednesday, January 15th. This represents a $0.48 annualized dividend and a dividend yield of 7.58%. The ex-dividend date is Monday, December 30th. View Manhattan Bridge Capital's Dividend History.

Manhattan Bridge Capital Inc. (NASDAQ:LOAN) announced its earnings results on Monday, October, 21st. The credit services provider reported $0.12 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.11 by $0.01. The credit services provider earned $1.92 million during the quarter. Manhattan Bridge Capital had a return on equity of 13.50% and a net margin of 59.32%. View Manhattan Bridge Capital's Earnings History.

Manhattan Bridge Capital is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Manhattan Bridge Capital.

2 brokerages have issued 1-year price objectives for Manhattan Bridge Capital's shares. Their forecasts range from $8.00 to $8.00. On average, they expect Manhattan Bridge Capital's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 26.4% from the stock's current price. View Analyst Price Targets for Manhattan Bridge Capital.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Manhattan Bridge Capital.

Media stories about LOAN stock have trended somewhat positive on Tuesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Manhattan Bridge Capital earned a news impact score of 2.0 on InfoTrie's scale. They also gave news headlines about the credit services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Manhattan Bridge Capital.

Manhattan Bridge Capital saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 1,700 shares, a drop of 48.5% from the December 15th total of 3,300 shares. Based on an average daily trading volume, of 24,300 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company's shares are sold short. View Manhattan Bridge Capital's Current Options Chain.

Some companies that are related to Manhattan Bridge Capital include CIM Commercial Trust (CMCT), Farmland Partners (FPI), Clipper Realty (CLPR), CBL & Associates Properties (CBL), Maxus Realty Trust (MRTI), Ellington Residential Mortgage REIT (EARN), Sachem Capital (SACH), SOTHERLY HOTELS/SH SH (SOHO), Postal Realty Trust (PSTL), Hunt Companies Finance Trust (HCFT), Tremont Mortgage Trust (TRMT), AMEN Properties (AMEN), Global Self Storage (SELF), Spirit MTA REIT (SMTA) and Medalist Diversified REIT (MDRR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer LP Unit (ET), NovaBay Pharmaceuticals (NBY), AcelRx Pharmaceuticals (ACRX), Corbus Pharmaceuticals (CRBP), Rigel Pharmaceuticals (RIGL), Actinium Pharmaceuticals (ATNM), Arbutus Biopharma (ABUS), ArQule (ARQL) and Athersys (ATHX).

Manhattan Bridge Capital's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Centric Wealth Management (0.43%). Company insiders that own Manhattan Bridge Capital stock include Assaf Ran, Eran Goldshmit and Lyron L Bentovim. View Institutional Ownership Trends for Manhattan Bridge Capital.

LOAN stock was bought by a variety of institutional investors in the last quarter, including Centric Wealth Management. View Insider Buying and Selling for Manhattan Bridge Capital.

Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LOAN stock can currently be purchased for approximately $6.33.

Manhattan Bridge Capital has a market capitalization of $61.14 million and generates $7.22 million in revenue each year. The credit services provider earns $4.20 million in net income (profit) each year or $0.48 on an earnings per share basis. Manhattan Bridge Capital employs 4 workers across the globe.View Additional Information About Manhattan Bridge Capital.

The official website for Manhattan Bridge Capital is http://www.manhattanbridgecapital.com/.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400.